10-12 September 2018 //  Lancaster Royal Hotel, London


David Brindley

Dr David Brindley

Senior Research Fellow in Healthcare Translation, Department of Paediatrics, University of Oxford

Dr David Brindley is an international research and industrial leader in healthcare translation. He holds academic appointments at the University of Oxford, Harvard, UCL, Stanford-UCSF-FDA Centre for Regulatory Sciences and CASMI, and is an enthusiastic and diligent advisor to a portfolio of healthcare sector companies, ranging from tools and technologies providers to life science focussed investors.

David is a Managing Partner at IP Asset Ventures Ltd. He is also Chief Scientific Officer of Aegate Ltd., who are world leaders in medicines authentication, ensuring compliance with the EU Falsified Medicines Directive (FMD) and US Drug Supply Chain Security Act (DSCSA).

2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad